Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

NCT00284206 is registered in ClinicalTrials.gov with Seattle Institute for Biomedical and Clinical Research as lead sponsor.

NCT NCT00284206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00284206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
Lead sponsor
Seattle Institute for Biomedical and Clinical Research
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
August 31, 2007
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine dependence